Aditya Bagrodia

Yeah. We're fine. Nothing kind of like starting to...

Okay.

Okay.

Okay.

0.1?

0.1?

0.1?

Yeah. I mean, so when, when you have a lower risk patient and you're hugging the bladder neck and you're hugging the nerves and you're hugging the apex, I mean, obviously you're not trying to leave any prostate cells behind. You're not trying to leave any gross volume of prostate behind, but what's your opinion on that? Like what is actually taking place?

Yeah. I mean, so when, when you have a lower risk patient and you're hugging the bladder neck and you're hugging the nerves and you're hugging the apex, I mean, obviously you're not trying to leave any prostate cells behind. You're not trying to leave any gross volume of prostate behind, but what's your opinion on that? Like what is actually taking place?

Yeah. I mean, so when, when you have a lower risk patient and you're hugging the bladder neck and you're hugging the nerves and you're hugging the apex, I mean, obviously you're not trying to leave any prostate cells behind. You're not trying to leave any gross volume of prostate behind, but what's your opinion on that? Like what is actually taking place?

So maybe let's just kind of parse out persistently elevated PSA. I hate that clinical state. It's so disappointing for everybody. I had a guy the other day who T3A, grade group three, negative margins, PSA wasn't particularly offensive. His six weeks was 0.2 and six weeks later is 0.4. And I'm just like, oh my gosh, this is... You know, this is super real.

So maybe let's just kind of parse out persistently elevated PSA. I hate that clinical state. It's so disappointing for everybody. I had a guy the other day who T3A, grade group three, negative margins, PSA wasn't particularly offensive. His six weeks was 0.2 and six weeks later is 0.4. And I'm just like, oh my gosh, this is... You know, this is super real.

So maybe let's just kind of parse out persistently elevated PSA. I hate that clinical state. It's so disappointing for everybody. I had a guy the other day who T3A, grade group three, negative margins, PSA wasn't particularly offensive. His six weeks was 0.2 and six weeks later is 0.4. And I'm just like, oh my gosh, this is... You know, this is super real.

So let's say that guy walks into your office and he's a consult for me. You got a second opinion from San Diego coming out to Michigan. What are the critical bits, pathology, PSA, history, et cetera? And what are additional tests that you want to get at that point?

So let's say that guy walks into your office and he's a consult for me. You got a second opinion from San Diego coming out to Michigan. What are the critical bits, pathology, PSA, history, et cetera? And what are additional tests that you want to get at that point?

So let's say that guy walks into your office and he's a consult for me. You got a second opinion from San Diego coming out to Michigan. What are the critical bits, pathology, PSA, history, et cetera? And what are additional tests that you want to get at that point?

Perfect. Spot on. So just a couple of thoughts. You mentioned the Gleason score, the margins, the time. Those are all kind of makes really good sense. If this patient were to use them as a case example. I also typically would still order MRIs of the pelvis post prostatectomy. Is there something that might not be quite as PSMA PET visible? Any opinions on that?

Perfect. Spot on. So just a couple of thoughts. You mentioned the Gleason score, the margins, the time. Those are all kind of makes really good sense. If this patient were to use them as a case example. I also typically would still order MRIs of the pelvis post prostatectomy. Is there something that might not be quite as PSMA PET visible? Any opinions on that?

Perfect. Spot on. So just a couple of thoughts. You mentioned the Gleason score, the margins, the time. Those are all kind of makes really good sense. If this patient were to use them as a case example. I also typically would still order MRIs of the pelvis post prostatectomy. Is there something that might not be quite as PSMA PET visible? Any opinions on that?

Yeah. Okay. So then, I mean, hopefully they've met with a radiation oncologist somewhere along the way to kind of run through all their options. I mean, obviously some patients are like, I want surgery and they get surgery and they may have had an opportunity to take advantage of the multidisciplinary team.